State Street Corp Lannett CO Inc Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.53 - $3.25 $66,600 - $408,398	-125,661 Closed	0 $0
Q2 2022 Aug 15, 2022	SELL	$0.47 - $0.87 $282 - $522	-600 Reduced 0.48%	125,661 $73,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.93 $14,664 - $27,542	-9,400 Reduced 6.93%	126,261 $205,000
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.83 $47,462 - $78,777	-16,310 Reduced 10.73%	135,661 $407,000
Q2 2021 Aug 16, 2021	SELL	$4.17 - $5.74 $3.88 Million - $5.34 Million	-929,694 Reduced 85.95%	151,971 $710,000
Q1 2021 May 17, 2021	SELL	$5.28 - $9.64 $882,097 - $1.61 Million	-167,064 Reduced 13.38%	1,081,665 $5.71 Million
Q4 2020 Feb 16, 2021	SELL	$5.75 - $7.13 $224,066 - $277,841	-38,968 Reduced 3.03%	1,248,729 $8.14 Million
Q3 2020 Nov 10, 2020	SELL	$4.9 - $7.12 $116,232 - $168,893	-23,721 Reduced 1.81%	1,287,697 $7.87 Million
Q2 2020 Aug 14, 2020	BUY	$6.43 - $9.86 $12,538 - $19,227	1,950 Added 0.15%	1,311,418 $9.52 Million
Q1 2020 May 11, 2020	BUY	$6.36 - $10.05 $8.33 Million - $13.2 Million	1,309,468 New	1,309,468 $9.1 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.